Gangadharam P R, Pratt P F, Damle P B, Davidson P T, Porter T H, Folkers K
Am Rev Respir Dis. 1978 Sep;118(3):467-73. doi: 10.1164/arrd.1978.118.3.467.
Because vitamin K is present in several species of mycobacteria, and because coenzyme Q has been found to stimulate the growth of Mycobacterium tuberculosis and atypical mycobacteria, 8 quinones that can be considered to be dual analogues of vitamin K and coenzyme Q were tested for their activity against Mycobacterium intracellulare. One compound, 6-cyclo-octylamino-5,8-quinolinequinone (CQQ) exhibited considerable activity in vitro against several strains of Mycobacterium intracellulare at a concentration of 8 micrograms per ml. It has also shown evidence of bactericidal activity against growing cultures of Mycobacterium intracellulare. Time exposure studies indicated that a minimal contact period of 24 hours with a concentration of 8 micrograms of CQQ per ml is necessary for permanent inhibitory action against Mycobacterium intracellulare. At a concentration of 1 microgram per ml, CQQ inhibited Mycobacterium tuberculosis, including the rifampin-resistant strains. The drug has no activity against rapidly growing mycobacteria or organisms that are not acid-fast.
由于维生素K存在于多种分枝杆菌中,并且已发现辅酶Q可刺激结核分枝杆菌和非典型分枝杆菌的生长,因此测试了8种可被视为维生素K和辅酶Q双重类似物的醌类化合物对胞内分枝杆菌的活性。一种化合物,6-环辛基氨基-5,8-喹啉醌(CQQ)在体外对几种胞内分枝杆菌菌株表现出相当的活性,浓度为每毫升8微克。它还显示出对生长中的胞内分枝杆菌培养物具有杀菌活性的证据。时间暴露研究表明,要对胞内分枝杆菌产生永久抑制作用,每毫升8微克CQQ的最低接触时间为24小时。在每毫升1微克的浓度下,CQQ可抑制结核分枝杆菌,包括耐利福平菌株。该药物对快速生长的分枝杆菌或非抗酸菌没有活性。